Related Experiment Video
Updated: Oct 14, 2025
08:52
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
9.0K
Primary Pulmonary Leiomyosarcoma in a Forty-Year-Old Woman
Ekin Ozluk1, Eric X Wei2, James Cotelingam1
1Department of Pathology & Translational Pathobiology, LSU Health Sciences Center Shreveport, Shreveport, Louisiana, USA.
Case Reports in Oncology
|November 1, 2021
Summary
Primary pulmonary leiomyosarcomas (PPLs) are rare lung cancers. Early detection is crucial to avoid misdiagnosis and improve patient outcomes for this aggressive malignancy.
Area of Science:
- Oncology
- Pathology
- Pulmonary Medicine
Background:
- Primary pulmonary leiomyosarcomas (PPLs) are rare, aggressive tumors arising from smooth muscle cells.
- PPLs constitute less than 0.5% of all lung tumors.
- These malignancies can originate in the pulmonary interstitium, bronchial tree, or blood vessels.
Observation:
- PPLs are frequently misdiagnosed as pulmonary emboli, cardiac tumors, or common lung cancers.
- Diagnostic delays in PPL can negatively impact patient prognosis.
- This report details a case of PPL in a 40-year-old female patient.
Findings:
- The case highlights the challenges in diagnosing PPL due to its rarity and nonspecific presentation.
- Accurate and timely diagnosis is essential for effective management of PPL.
- This case underscores the importance of considering rare diagnoses in challenging clinical scenarios.
Implications:
- Improved awareness and diagnostic strategies for PPL are needed.
- Early recognition can lead to prompt treatment and potentially better patient outcomes.
- Further research into the pathogenesis and optimal treatment of PPL is warranted.
